secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2025-02-04T23:59:59+00:00
Accession:  0001104659-25-009137
Event type: other_material
Sentiment:  positive
Materiality: 0.20
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Quoin launches Netherton NOW campaign for rare disease awareness
----------------------------------------------------------------

- Campaign 'NETHERTON NOW' launched Feb 4, 2025 to raise awareness for Netherton Syndrome.
- 20% of babies with Netherton Syndrome estimated not to survive, per company.
- Quoin has four ongoing clinical studies evaluating QRX003 for Netherton Syndrome.
- As of Feb 4, 2025, outstanding ordinary shares (ADS) total 20,585,830.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465925009137/0001104659-25-009137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465925009137/tm255460d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-009137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer